Collaboration key for xenotransplants

Non-rejecting pigs advance xenotransplantation but input from other fields is needed to optimize future progress.

Written byTabitha Powledge
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WASHINGTON, DC — Prospects for successful xenotransplantation — therapeutic transplants of animal organs and tissues into humans — are improving. But workers in the field caution that there is still a long way to go before organs from animals will be able to fix the perpetual shortfall in the supply of human transplant tissues.

These were the key conclusions at the 11/12 March 2002 Advisory Committee on Xenotransplantation (SACX) meeting at the US Department of Health and Human Services (DHHS), at which brought committee members were brought up to date on recent studies.

Established in 1999, SACX meets quarterly, and will eventually put together reports on the state-of-the-art, safety issues and informed consent, destined for the desk of DHHS Secretary Tommy Thompson, a Bush appointee. The most cheering news discussed at the meeting was the recent production of transgenic piglets lacking a gene that triggers immune system rejection in humans.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA